Watchlist Price Alert

Soleno Therapeutics Inc. (SLNO)

NASDAQ: SLNO · Real-Time Price · USD

75.04

1.58 (2.15%)

At close: May 15, 2025, 3:59 PM

Soleno Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	87.93M	169.68M	14.6M	21.3M	49.22M	20.73M	23.1M	17.1M	2.73M
Short-Term Investments	203.51M	n/a	n/a	n/a	n/a	n/a	978K	n/a	n/a
Long-Term Investments	27.21M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	83K	165K	n/a	40K	n/a	59K	n/a	591.92K	125.53K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	64K	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	660.39K
Other Current Assets	2.45M	1.68M	1.04M	1.12M	1.02M	411K	n/a	551K	828.73K
Total Current Assets	293.89M	171.36M	15.65M	22.42M	50.24M	21.14M	24.67M	17.99M	3.8M
Property-Plant & Equipment	2.98M	419K	157K	454K	158K	444K	12K	22.89K	102.56K
Goodwill & Intangibles	6.8M	8.75M	10.69M	12.64M	14.58M	16.52M	18.47M	20.41M	1.54M
Total Long-Term Assets	37.08M	9.33M	10.85M	13.13M	14.74M	17.03M	18.48M	21.03M	1.76M
Total Assets	330.97M	180.69M	26.5M	35.55M	64.98M	38.17M	43.15M	39.02M	5.56M
Account Payables	8.88M	3.15M	1.78M	3.25M	3.49M	2M	934K	633K	410.51K
Deferred Revenue	n/a	n/a	n/a	4.15M	4.79M	2.28M	n/a	n/a	n/a
Short-Term Debt	526K	n/a	155K	282K	n/a	305K	n/a	n/a	n/a
Other Current Liabilities	9.34M	4.95M	3.55M	769K	196K	2.66M	623K	127K	246.4K
Total Current Liabilities	18.75M	11.51M	7.31M	8.01M	8.62M	4.96M	1.88M	1.73M	1.71M
Long-Term Debt	49.83M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	14.81M	11.55M	8.84M	9.58M	10.82M	18.26M	10.86M	10.47M	422.28K
Total Long-Term Liabilities	67.11M	11.68M	8.84M	9.75M	10.82M	18.26M	10.86M	10.75M	422.28K
Total Liabilities	85.86M	23.18M	16.15M	17.76M	19.43M	23.23M	12.74M	12.49M	2.13M
Total Debt	52.83M	403K	155K	457K	139K	305K	n/a	n/a	n/a
Common Stock	46K	32K	8K	80K	80K	45K	32K	19.24K	16.79K
Retained Earnings	-452.26M	-276.41M	-237.42M	-213.35M	-182.44M	-157.81M	-127.03M	-113.98M	-98.31M
Comprehensive Income	n/a	0.00	n/a	-0.00	n/a	n/a	-93K	-73.65K	-159.36K
Shareholders Equity	245.11M	157.51M	10.35M	17.79M	45.55M	14.95M	30.41M	26.53M	3.44M
Total Investments	230.72M	n/a	n/a	n/a	n/a	n/a	978K	n/a	n/a